Skip to Content Skip to Search
About us new hero

About us

We are a science-led global healthcare company with a special purpose to improve the quality of human life by helping people do more, feel better, live longer.

Arthur, Oncology Scientist, US

Every day, we help improve the health of millions of people around the world by discovering, developing and manufacturing innovative medicines, vaccines and consumer healthcare products. 

We are building a stronger purpose and performance culture underpinned by our values and expectations - so that together we can deliver extraordinary impact for patients and consumers and make GSK a brilliant place to work.

Our values are Patient focus, Transparency, Respect, Integrity.
Our expectations are Courage, Accountability, Development, Teamwork.

What we do

We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, preventing and treating disease and keeping people well with our scientific and technical know-how and talented people.


T-cells attacking a cancer cell
Immune system T-cells attacking a cancer cell


Herpes zoster virus of shingles
Herpes zoster virus of shingles

Consumer Healthcare

Novamin, a key technology in Sensodyne
Novamin, a key technology in Sensodyne Repair and Protect

How we do it

Everyone at GSK is focused on our three long-term priorities - Innovation, Performance, Trust - underpinned by our ambition to build a more purpose and performance driven culture, aligned to our values.


We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.

  • £4.8bn

    adjusted R&D investment in 2021

  • 43

    new medicines in development at FY 2021

  • 21

    new vaccines in development at FY 2021


We deliver growth by investing effectively in our business, developing our people and executing competitively.

  • £34.1bn

    Group turnover in 2021

  • £8.8bn

    adjusted operating profit in 2021

  • £4.4bn

    free cash flow in 2021

  • £4bn

    dividends paid in 2021


We are a responsible company. We commit to use our science and technology to address health needs, make our products affordable and available and be a modern employer.

  • 78%

    employee engagement score on our latest employee survey

  • 1st

    in Access to Medicines Index since the assessment began in 2008